About Dr. Alsaab
Dr. Ayham Alsaab, DO, MD, is an Internal Medicine physician dedicated to providing compassionate, high-quality, and evidence-based care to adult patients. With more than two decades of medical experience, Dr. Alsaab has practiced in multiple healthcare systems across the Middle East, Europe, and the United States, bringing a broad international perspective to patient care.
Dr. Alsaab focuses on preventive medicine, chronic disease management, and the comprehensive care of patients with complex medical conditions. He believes in developing personalized treatment plans and building strong physician-patient relationships to help patients achieve their best health outcomes.
In addition to his clinical work, Dr. Alsaab has a strong interest in medical research and regenerative medicine. His academic interests include stem cell therapies, exosome therapy, and emerging regenerative approaches that may improve patient care and quality of life.
Education
Dr. Alsaab holds both Doctor of Medicine (MD) and Doctor of Osteopathic Medicine (DO) degrees.
- Doctor of Osteopathic Medicine (DO)
New York Institute of Technology College of Osteopathic Medicine
Old Westbury, New York, 2022 - Regenerative Medicine Training
Texas Heart Institute
Houston, Texas, 2017 - Doctor of Medicine (MD)
University of Aleppo Faculty of Medicine
Aleppo, Syria, 1998
Training
- Internal Medicine Residency (ACGME Accredited)
HCA Medical City Arlington
Arlington, Texas, 2022-2025 - Internal Medicine Residency
Military Hospitals, Syria, 2001-2004
Medical Interests
- Preventive Medicine
- Chronic Disease Management
- Regenerative Medicine
- Multipotent Stem Cell (MPSC) Research
- Exosome Therapy
- Polynucleotide (PDRN) Therapy
- Evidence-Based Medicine
- Patient Education and Wellness
Research & Publications
Dr. Alsaab has contributed to several peer-reviewed publications and research projects in cardiology, nephrology, autoimmune diseases, and regenerative medicine, including:
- Usefulness of T-Wave Inversion to Predict Spontaneous Reperfusion in STEMI (American Journal of Cardiology, 2014)
- Severe Hypokalemic Paralysis Following Rituximab Infusion in a Patient With Microscopic Polyangiitis (Cureus, 2025)
- ADEM as an Initial Presentation of SLE: A Case Report (2024)
- Severe Hypokalemic Paralysis Following Rituximab Infusion in a Patient With Type I Renal Tubular Acidosis (2025)
- Immune Response to DNA in Decellularized Extracellular Matrix (dECM) Research (2016)
Personal
Dr. Alsaab is married and the proud father of four children. Outside of medicine, he enjoys spending time with his family, continuing medical education, and exploring innovations in regenerative medicine and patient care.
